Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer von Gijtenbeek, R.G.P., Noort, V. van der, Aerts, J.G.J.V., Staal-Van den Brekel, J.A., Smit, E.F., Krouwels, F.H., Wilschut, F.A., Hiltermann, T.J.N., Timens, W., Schuuring, E., Janssen, J.D.J., Goosens, M., Berg, P.M. van den, Langen, A.J. de, Stigt, J.A., Borne, B.E.M. van den, Groen, H.J.M., Geffen, W.H. van, Wekken, A.J. van der

Volltext bestellen